Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253

G. Donohoe, J. Walters, A. Hargreaves, E. J. Rose, D. W. Morris, C. Fahey, S. Bellini, E. Cummins, I. Giegling, A. M. Hartmann, H. J. Möller, P. Muglia, M. J. Owen, M. Gill, M. C. O'Donovan, D. Tropea, D. Rujescu, A. Corvin

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The single-nucleotide polymorphism (SNP) rs10503253, located within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2, was recently identified as genome-wide significant for schizophrenia (SZ), but is of unknown function. We investigated the neurocognitive effects of this CSMD1 variant in vivo in patients and healthy participants using behavioral and imaging measures of brain structure and function. We compared carriers and non-carriers of the risk 'A' allele on measures of neuropsychological performance typically impaired in SZ (general cognitive ability, episodic and working memory and attentional control) in independent samples of Irish patients (n=387) and controls (n=171) and German patients (205) and controls (n=533). Across these groups, the risk 'A' allele at CSMD1 was associated with deleterious effects across a number of neurocognitive phenotypes. Specifically, the risk allele was associated with poorer performance on neuropsychological measures of general cognitive ability and memory function but not attentional control. These effects, while significant, were subtle, and varied between samples. Consistent with previous evidence suggesting that CSMD1 may be involved in brain mechanisms related to memory and learning, these data appear to reflect the deleterious effects of the identified 'A' risk allele on neurocognitive function, possibly as part of the mechanism by which CSMD1 is associated with SZ risk. The CSMD1 variant rs10503253, a genome-wide supported schizophrenia risk variant, is associated with subtle deficits on a range of neuropsychological measures in patients with schizophrenia and controls.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalGenes, Brain and Behavior
Volume12
Issue number2
DOIs
StatePublished - Mar 1 2013

Fingerprint

Schizophrenia
Genome
Alleles
Aptitude
Episodic Memory
Short-Term Memory
Neuroimaging
Single Nucleotide Polymorphism
Healthy Volunteers
Learning
Phenotype
Brain
Genes

All Science Journal Classification (ASJC) codes

  • Genetics
  • Neurology
  • Behavioral Neuroscience

Cite this

Donohoe, G. ; Walters, J. ; Hargreaves, A. ; Rose, E. J. ; Morris, D. W. ; Fahey, C. ; Bellini, S. ; Cummins, E. ; Giegling, I. ; Hartmann, A. M. ; Möller, H. J. ; Muglia, P. ; Owen, M. J. ; Gill, M. ; O'Donovan, M. C. ; Tropea, D. ; Rujescu, D. ; Corvin, A. / Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. In: Genes, Brain and Behavior. 2013 ; Vol. 12, No. 2. pp. 203-209.
@article{3eb71563fa4842e09eac8bc2f18a9e79,
title = "Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253",
abstract = "The single-nucleotide polymorphism (SNP) rs10503253, located within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2, was recently identified as genome-wide significant for schizophrenia (SZ), but is of unknown function. We investigated the neurocognitive effects of this CSMD1 variant in vivo in patients and healthy participants using behavioral and imaging measures of brain structure and function. We compared carriers and non-carriers of the risk 'A' allele on measures of neuropsychological performance typically impaired in SZ (general cognitive ability, episodic and working memory and attentional control) in independent samples of Irish patients (n=387) and controls (n=171) and German patients (205) and controls (n=533). Across these groups, the risk 'A' allele at CSMD1 was associated with deleterious effects across a number of neurocognitive phenotypes. Specifically, the risk allele was associated with poorer performance on neuropsychological measures of general cognitive ability and memory function but not attentional control. These effects, while significant, were subtle, and varied between samples. Consistent with previous evidence suggesting that CSMD1 may be involved in brain mechanisms related to memory and learning, these data appear to reflect the deleterious effects of the identified 'A' risk allele on neurocognitive function, possibly as part of the mechanism by which CSMD1 is associated with SZ risk. The CSMD1 variant rs10503253, a genome-wide supported schizophrenia risk variant, is associated with subtle deficits on a range of neuropsychological measures in patients with schizophrenia and controls.",
author = "G. Donohoe and J. Walters and A. Hargreaves and Rose, {E. J.} and Morris, {D. W.} and C. Fahey and S. Bellini and E. Cummins and I. Giegling and Hartmann, {A. M.} and M{\"o}ller, {H. J.} and P. Muglia and Owen, {M. J.} and M. Gill and O'Donovan, {M. C.} and D. Tropea and D. Rujescu and A. Corvin",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/gbb.12016",
language = "English (US)",
volume = "12",
pages = "203--209",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",
number = "2",

}

Donohoe, G, Walters, J, Hargreaves, A, Rose, EJ, Morris, DW, Fahey, C, Bellini, S, Cummins, E, Giegling, I, Hartmann, AM, Möller, HJ, Muglia, P, Owen, MJ, Gill, M, O'Donovan, MC, Tropea, D, Rujescu, D & Corvin, A 2013, 'Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253', Genes, Brain and Behavior, vol. 12, no. 2, pp. 203-209. https://doi.org/10.1111/gbb.12016

Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. / Donohoe, G.; Walters, J.; Hargreaves, A.; Rose, E. J.; Morris, D. W.; Fahey, C.; Bellini, S.; Cummins, E.; Giegling, I.; Hartmann, A. M.; Möller, H. J.; Muglia, P.; Owen, M. J.; Gill, M.; O'Donovan, M. C.; Tropea, D.; Rujescu, D.; Corvin, A.

In: Genes, Brain and Behavior, Vol. 12, No. 2, 01.03.2013, p. 203-209.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253

AU - Donohoe, G.

AU - Walters, J.

AU - Hargreaves, A.

AU - Rose, E. J.

AU - Morris, D. W.

AU - Fahey, C.

AU - Bellini, S.

AU - Cummins, E.

AU - Giegling, I.

AU - Hartmann, A. M.

AU - Möller, H. J.

AU - Muglia, P.

AU - Owen, M. J.

AU - Gill, M.

AU - O'Donovan, M. C.

AU - Tropea, D.

AU - Rujescu, D.

AU - Corvin, A.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - The single-nucleotide polymorphism (SNP) rs10503253, located within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2, was recently identified as genome-wide significant for schizophrenia (SZ), but is of unknown function. We investigated the neurocognitive effects of this CSMD1 variant in vivo in patients and healthy participants using behavioral and imaging measures of brain structure and function. We compared carriers and non-carriers of the risk 'A' allele on measures of neuropsychological performance typically impaired in SZ (general cognitive ability, episodic and working memory and attentional control) in independent samples of Irish patients (n=387) and controls (n=171) and German patients (205) and controls (n=533). Across these groups, the risk 'A' allele at CSMD1 was associated with deleterious effects across a number of neurocognitive phenotypes. Specifically, the risk allele was associated with poorer performance on neuropsychological measures of general cognitive ability and memory function but not attentional control. These effects, while significant, were subtle, and varied between samples. Consistent with previous evidence suggesting that CSMD1 may be involved in brain mechanisms related to memory and learning, these data appear to reflect the deleterious effects of the identified 'A' risk allele on neurocognitive function, possibly as part of the mechanism by which CSMD1 is associated with SZ risk. The CSMD1 variant rs10503253, a genome-wide supported schizophrenia risk variant, is associated with subtle deficits on a range of neuropsychological measures in patients with schizophrenia and controls.

AB - The single-nucleotide polymorphism (SNP) rs10503253, located within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2, was recently identified as genome-wide significant for schizophrenia (SZ), but is of unknown function. We investigated the neurocognitive effects of this CSMD1 variant in vivo in patients and healthy participants using behavioral and imaging measures of brain structure and function. We compared carriers and non-carriers of the risk 'A' allele on measures of neuropsychological performance typically impaired in SZ (general cognitive ability, episodic and working memory and attentional control) in independent samples of Irish patients (n=387) and controls (n=171) and German patients (205) and controls (n=533). Across these groups, the risk 'A' allele at CSMD1 was associated with deleterious effects across a number of neurocognitive phenotypes. Specifically, the risk allele was associated with poorer performance on neuropsychological measures of general cognitive ability and memory function but not attentional control. These effects, while significant, were subtle, and varied between samples. Consistent with previous evidence suggesting that CSMD1 may be involved in brain mechanisms related to memory and learning, these data appear to reflect the deleterious effects of the identified 'A' risk allele on neurocognitive function, possibly as part of the mechanism by which CSMD1 is associated with SZ risk. The CSMD1 variant rs10503253, a genome-wide supported schizophrenia risk variant, is associated with subtle deficits on a range of neuropsychological measures in patients with schizophrenia and controls.

UR - http://www.scopus.com/inward/record.url?scp=84874147897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874147897&partnerID=8YFLogxK

U2 - 10.1111/gbb.12016

DO - 10.1111/gbb.12016

M3 - Article

C2 - 23320435

AN - SCOPUS:84874147897

VL - 12

SP - 203

EP - 209

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

IS - 2

ER -